Nextwave Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for NEXTWAVE, and what generic alternatives to NEXTWAVE drugs are available?
NEXTWAVE has two approved drugs.
There are fifteen US patents protecting NEXTWAVE drugs.
There are thirty-four patent family members on NEXTWAVE drugs in fourteen countries.
Drugs and US Patents for Nextwave
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nextwave | QUILLIVANT XR | methylphenidate hydrochloride | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 202100-001 | Sep 27, 2012 | AB | RX | Yes | Yes | 8,062,667 | See Plans and Pricing | Y | See Plans and Pricing | ||
Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-002 | Dec 4, 2015 | RX | Yes | No | 9,844,544 | See Plans and Pricing | Y | See Plans and Pricing | |||
Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-001 | Dec 4, 2015 | RX | Yes | No | 8,202,537 | See Plans and Pricing | Y | See Plans and Pricing | |||
Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-003 | Dec 4, 2015 | RX | Yes | Yes | 11,103,494 | See Plans and Pricing | Y | See Plans and Pricing | |||
Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-003 | Dec 4, 2015 | RX | Yes | Yes | 11,103,495 | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for NEXTWAVE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Oral Suspension | 5 mg/mL | ➤ Subscribe | 2013-08-02 |
International Patents for Nextwave Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2017202955 | See Plans and Pricing |
European Patent Office | 2884961 | See Plans and Pricing |
Denmark | 2428205 | See Plans and Pricing |
Russian Federation | 2435569 | See Plans and Pricing |
Japan | 5479086 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.